Low cost extraction and isothermal amplification of DNA for infectious diarrhea diagnosis
Date Issued
2013-03-28Publisher Version
10.1371/journal.pone.0060059Author(s)
Huang, Shichu
Do, Jaephil
Mahalanabis, Madhumita
Fan, Andy
Zhao, Lei
Jepeal, Lisa
Singh, Satish K.
Klapperich, Catherine M.
Metadata
Show full item recordPermanent Link
https://hdl.handle.net/2144/40736Version
Final published version
Citation (published version)
Shichu Huang, Jaephil Do, Madhumita Mahalanabis, Andy Fan, Lei Zhao, Lisa Jepeal, Satish K. Singh, Catherine M. Klapperich. 2013. "Low Cost Extraction and Isothermal Amplification of DNA for Infectious Diarrhea Diagnosis." PLOS ONE, Volume 8, Issue 3. https://doi.org/10.1371/journal.pone.0060059Abstract
In order to counter the common perception that molecular diagnostics are too complicated to work in low resource settings, we have performed a difficult sample preparation and DNA amplification protocol using instrumentation designed to be operated without wall or battery power. In this work we have combined a nearly electricity-free nucleic acid extraction process with an electricity-free isothermal amplification assay to detect the presence of Clostridium difficile (C. difficile) DNA in the stool of infected patients. We used helicase-dependent isothermal amplification (HDA) to amplify the DNA in a low-cost, thermoplastic reaction chip heated with a pair of commercially available toe warmers, while using a simple Styrofoam insulator. DNA was extracted from known positive and negative stool samples. The DNA extraction protocol utilized an air pressure driven solid phase extraction device run using a standard bicycle pump. The simple heater setup required no electricity or battery and was capable of maintaining the temperature at 65°C±2°C for 55 min, suitable for repeatable HDA amplification. Experiments were performed to explore the adaptability of the system for use in a range of ambient conditions. When compared to a traditional centrifuge extraction protocol and a laboratory thermocycler, this disposable, no power platform achieved approximately the same lower limit of detection (1.25×10−2 pg of C. difficile DNA) while requiring much less raw material and a fraction of the lab infrastructure and cost. This proof of concept study could greatly impact the accessibility of molecular assays for applications in global health.
Rights
© 2013 Huang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.Collections